| Literature DB >> 31268604 |
Parash Parajuli1, Purba Singh2, Zhe Wang2, Lianna Li2, Sailaja Eragamreddi2, Seval Ozkan2, Olivier Ferrigno3, Celine Prunier3, Mohammed S Razzaque4, Keli Xu2, Azeddine Atfi1,3.
Abstract
A prominent function of TGIF1 is suppression of transforming growth factor beta (TGF-β) signaling, whose inactivation is deemed instrumental to the progression of pancreatic ductal adenocarcinoma (PDAC), as exemplified by the frequent loss of the tumor suppressor gene SMAD4 in this malignancy. Surprisingly, we found that genetic inactivation of Tgif1 in the context of oncogenic Kras, KrasG12D , culminated in the development of highly aggressive and metastatic PDAC despite de-repressing TGF-β signaling. Mechanistic experiments show that TGIF1 associates with Twist1 and inhibits Twist1 expression and activity, and this function is suppressed in the vast majority of human PDACs by KrasG12D /MAPK-mediated TGIF1 phosphorylation. Ablating Twist1 in KrasG12D ;Tgif1KO mice completely blunted PDAC formation, providing the proof-of-principle that TGIF1 restrains KrasG12D -driven PDAC through its ability to antagonize Twist1. Collectively, these findings pinpoint TGIF1 as a potential tumor suppressor in PDAC and further suggest that sustained activation of TGF-β signaling might act to accelerate PDAC progression rather than to suppress its initiation.Entities:
Keywords: TGF-β signaling; TGIF1; Twist1; oncogenic Kras; pancreatic ductal adenocarcinoma
Mesh:
Substances:
Year: 2019 PMID: 31268604 PMCID: PMC6601038 DOI: 10.15252/embj.2018101067
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598